Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1923]
News [3529]
Articles [90]
Editorials [5]
Conferences [156]
elearning [19]
Advanced prostate cancer overview: Expert discussion
Dr Heather Payne, Prof Romano Danesi, Prof Luis da Costa, Prof Peter Mulders
Advanced prostate cancer overview: Expert discussion ( Dr Heather Payne, Prof Romano Danesi, Prof Luis da Costa, Prof Peter Mulders )
27 Jan 2016
Entinostat and high-dose Interleukin 2 in renal cell carcinoma patients
Prof Roberto Pili - Indiana University, Indianapolis, USA
Entinostat and high-dose Interleukin 2 in renal cell carcinoma patients ( Prof Roberto Pili - Indiana University, Indianapolis, USA )
9 Jan 2016
Best of ASCO GU 2016 prostate cancer data
Prof Noel Clarke, Dr Heather Payne, Prof Peter Iverson
Best of ASCO GU 2016 prostate cancer data ( Prof Noel Clarke, Dr Heather Payne, Prof Peter Iverson )
8 Jan 2016
Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancer
Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )
8 Jan 2016
Avelumab for metastatic urothelial carcinoma: JAVELIN trial
Dr Andrea Apolo - National Cancer Institute, Maryland, USA
Avelumab for metastatic urothelial carcinoma: JAVELIN trial ( Dr Andrea Apolo - National Cancer Institute, Maryland, USA )
8 Jan 2016
Integrated genomic correlates of response to PD-1 inhibitor nivolumab in mRCC
Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA
Integrated genomic correlates of response to PD-1 inhibitor nivolumab in mRCC ( Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA )
8 Jan 2016
Impact of metformin on outcomes for metastatic renal cell carcinoma
Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA
Impact of metformin on outcomes for metastatic renal cell carcinoma ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )
8 Jan 2016
ASCO GU 2016: Highlights
Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
ASCO GU 2016: Highlights ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
8 Jan 2016
Atezolizumab for platinum-treated locally advanced or metastatic urothelial...
Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA
Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma ( Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA )
8 Jan 2016
Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer
Prof Eleni Efstathiou and Prof Nick James
Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer ( Prof Eleni Efstathiou and Prof Nick James )
7 Jan 2016
Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours
Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours ( Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy )
7 Jan 2016
Survival outcomes from the CALGB 40603 study in triple-negative breast cancer
Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA
Survival outcomes from the CALGB 40603 study in triple-negative breast cancer ( Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA )
17 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation